Insider · CIK 0001405637
Vickie S Reed
Files at EVOK (Evoke Pharma Inc). First filing -, latest -.
Vickie S Reed files SEC Form 4 as director at EVOK (Evoke Pharma Inc). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Vickie S Reed has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 17, 2025 | EVOK Evoke Pharma Inc | DDisposition to issuer Stock Option (Right to Buy)derivative | -1,250 | - | - | 0 | Dec 17, 2025 |
| Dec 17, 2025 | EVOK Evoke Pharma Inc | DDisposition to issuer Stock Option (Right to Buy)derivative | -5,833 | - | - | 0 | Dec 17, 2025 |
| Dec 17, 2025 | EVOK Evoke Pharma Inc | DDisposition to issuer Stock Option (Right to Buy)derivative | -1,250 | - | - | 0 | Dec 17, 2025 |
| May 21, 2025 | EVOK Evoke Pharma Inc | AGrant or award Stock Option (Right to Buy)derivative | +1,250 | $0.00 | $0 | 8,333 | May 22, 2025 |
| Jan 28, 2025 | EVOK Evoke Pharma Inc | AGrant or award Stock Option (Right to Buy)derivative | +5,833 | $0.00 | $0 | 5,833 | Jan 29, 2025 |
Questions about Vickie S Reed
Answered from the filings on this page, as of the latest one.
Is Vickie S Reed buying or selling?
Vickie S Reed has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Vickie S Reed's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Vickie S Reed has 0.
Where does Vickie S Reed file Form 4?
Vickie S Reed has filed Form 4 at EVOK (Evoke Pharma Inc). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.